MTBVAC, the TB vaccine, has undergone Phase I and II clinical trials in India. The vaccine has demonstrated safety and immunogenicity. Base...

Bharat Biotech and GSK plc have partnered to develop a vaccine for Shigellosis, a severe bacterial diarrhea. The altSonflex1-2-3 vaccine ca...

Bharat Biotech unveiled Hillchol, a new single-strain oral cholera vaccine, developed with Hilleman Laboratories. Addressing the high globa...

Responding to Trinamool Congress member Sougata Roy, who had asked whether the government took any punitive action against the company for ...

Bharat Biotech on Tuesday said it has collaborated with the Netherlands-based Bilthoven Biologicals B.V, a wholly-owned arm of Serum Instit...

Japan has included Bharat Biotech's Covaxin in the list of recognised vaccines, a move aimed at facilitating travel between the two countri...

"For the millions who have received COVAXIN, the vaccine certificates issued still stand valid as there is no impact on efficacy and safety...

Hyderabad-based Bharat Biotech, which has developed Covaxin, submitted EOI (Expression of Interest) to the WHO on April 19 for the vaccine'...

"This represents one of the first approvals worldwide for COVID-19 vaccines for the 2-18 age group. Bharat Biotech sincerely thanks the DCG...

The latest 'Status of COVID-19 vaccines within WHO EUL/PQ evaluation process' guidance document dated September 29 on the WHO website said ...

CEPI first partnered with IVI and Bharat Biotech in June 2020, providing up to USD 14.1 million for vaccine manufacturing and clinical deve...

Bharat Biotech intends to submit documentation for emergency use authorisation to several additional countries worldwide, the company said.

Bharat Biotech's pre-submission meeting has been scheduled on June 23 for evaluation of the World Health Organisation (WHO)'s Emergency Use...

Bharat Biotech’s Covaxin is India’s first indigenous coronavirus vaccine. The DCGI’s approval of Covaxin, despite it not having phase-3 cli...

The indigenous, inactivated vaccine is being developed and manufactured in Bharat Biotech's BSL-3 (Bio-Safety Level 3) bio-containment faci...

Bharat Biotech has signed up 13,000 volunteers for the Phase 3 trial, backed by India's government medical research body, and is progressin...

"This is India's first phase-III efficacy study for a Covid-19 vaccine, and the largest phase-III efficacy trial ever conducted in India," ...